The problems affecting the Oxford drug have continued as the Netherlands suspends drug administration. The government has said it is a precautionary decision.
The Netherlands suspends Oxford jab
The Dutch authorities are now the latest nation to ban the Oxford Drug in Europe after concerns about side - effects of clots. This move was taken as a precaution till at least April 28. Ireland was the first country to ban taking the jab before Norway followed suit last week.
However, the World Health agency has said there isn't any relationship between the drug and increasing rates of a blood clot. Also, the European medicine commission (EMA) said its review shows the occurrence is more of a chance, and the pros outweigh the cons. Nations like Bulgaria, Iceland, Thailand, and Denmark have already stopped the administration of the jab.
According to the statement released by the government, this decision was more of a precaution than reactive. '' We want to avoid any problems with vaccinations, therefore this suspension is just temporary. '' Minister of health Hugo de Jonge said.
'' It is important to ascertain that everything is 100% correct.''
Suspension to affect vaccine administration
Due to these issues, there would be a slight delay in Vaccination procedures. The Dutch authorities have ordered about 11 doses of the Oxford drug with more than 260,000 expected to arrive next week. AstraZeneca has insisted that there is no evidence that its drugs cause a blood clot, and that recent discoveries may be a coincidence.
It says its doctors are constantly checked for any anomalies but has found nothing. It noted that though there are various side effects of the drug, blood clotting isn't part of them. They have continuously been backed by various international health agencies and have continued to supply several nations. They would hope this matter will be solved soon.